Baiyang Pharmaceutical

Baiyang Pharmaceutical is a leading Chinese pharmaceutical company specializing in the development, manufacturing, and commercialization of high-end solid oral dosage forms. The company is renowned for its advanced drug delivery systems, particularly its proprietary osmotic pump controlled-release technology, which enhances the efficacy and safety of chronic disease treatments. Its product portfolio includes high-quality generics and innovative formulations targeting diabetes, hypertension, and cardiovascular diseases, many of which have received both Chinese NMPA and US FDA approvals. As part of the broader Baiyang Investment Group, the company leverages a robust commercialization network to bridge the gap between global pharmaceutical innovations and the Chinese healthcare market. Baiyang is committed to international standards, maintaining state-of-the-art manufacturing facilities that comply with global GMP requirements.